Wednesday, April 05, 2017 4:40:30 AM
By Mack Tyler - April 4, 2017 Delcath Systems, Inc. (DCTH) has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock. This is the breakdown as we see it. Contrary to popular belief, ignorance is not bliss. What you don’t know can actually harm you; and if you are a day trader, $1 worth of ignorance could potentially cost you $100 in real wealth. Traders that succeed know this; which is why many don’t take on any trade unless they listen intently to what the technical chart has to say.
The 50 and 200 SMAs for DCTH have created a marked trend which is now helping traders to make solid decisions regarding the stock. It’s a trend that is now unmistakable. Based on the trend levels presented by both indicators, the overall sentiment towards DCTH is best described as bearish. This trend has created a unified opinion across the trading floor and it is clear that the overall outlook for the stock is now established as negative. But it’s not just the outlook that’s being affected for the stock. Thanks to the consolidated opinion on DCTH, activity has also seen a pronounced trend. Under current sentiments the volume activity and subsequent trend has created a strong outlook from buyers and sellers. Sentiments have a tendency to either weaken or strengthen as other technical factors begin to influence overall outlook. It’s interesting to see how things are playing out for DCTH. It is unsurprising in the case of DCTH, that the current trend has created some enthusiasm among traders regarding the stock. In terms of consistency, it is clear that both the 50 and 200 SMAs have done their job in bring traders the overall trend-picture currently being seen for DCTH.
There is of course more to the tale than just what the SMAs have presented. For those added details, we can take a look at the Relative strength indicator (RSI) and Stochastic measures, both of which give deeper insights into the overall sentiment of buyers and sellers. SMAs will tell alert you to price direction, but when it comes to judging what buyers and sellers are doing, few indicators are better than RSI and the Stochastic. It as this level of technical data that a trader can determine whether a stock is currently overbought is oversold. The current picture for DCTH is of course very telling based on these two additional measures. Based on current readings, DCTH’s 14-day RSI is 26.85%. Taken on the standard scale of measurement for RSI, this suggests that DCTH is currently oversold, suggesting that the stock may have hit a floor and could potentially see an uptick. The stochastic reading offers another solid measure of whether the stock is either overbought, or oversold. In the case of DCTH, Stochastic readings gathered over the last 30 days have created a score of 11.43%. This suggests DCTH is oversold at current levels.
The best strategy for using technical analysis is of course to layer on as many indicators as can fit within a singular structure – a point of view, if you like. The above indicators really start to shine when you boost them by adding other indicators into the mix. By this point in the analysis of DCTH, it is clear that other technical indicators are saying essentially the same things. Specifically the -0.06 has birthed a negative overall sentiment when measured over the previous 30 days or so of trading. Over the longer-term DCTH has underperform the S&P 500 by -115.42. This has, unsurprisingly, created higher volatility levels when compared with similar stocks of the same grade and class. Historical volatility is no less consistent. The historical volatility picture for DCTH is shown in the reading of 111.65%. DCTH has clearly shown its full hand by the overall input of these technical indicators. But there is one final measure that when added to the already rich mix, shows in full color what DCTH is doing. The indicator is the Average True Range, and based on the current 30 reading, DCTH is certainly worth paying attention to.
DCTH couldn’t be clearer in terms of the kind of action required in light of the picture shown by its technical indicators.
http://nystocknews.com/2017/04/04/the-technical-chart-for-delcath-systems-inc-dcth-has-spoken-2/
Recent DCTH News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/17/2024 04:48:32 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 05/16/2024 06:05:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 05:09:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 04:56:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 04:45:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 01:14:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 12:05:15 PM
- Delcath Systems Reports First Quarter 2024 Results and Business Highlights • PR Newswire (US) • 05/14/2024 11:30:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/09/2024 09:12:20 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/08/2024 08:02:02 PM
- Delcath Systems to Host First Quarter 2024 Earnings Call • PR Newswire (US) • 05/07/2024 12:30:00 PM
- Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT • PR Newswire (US) • 05/06/2024 01:00:00 PM
- Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 05/03/2024 09:15:00 PM
- Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/04/2024 12:35:00 PM
- Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update • PR Newswire (US) • 03/26/2024 11:30:00 AM
- Delcath Systems Closes $7 Million Private Placement • PR Newswire (US) • 03/20/2024 12:15:00 PM
- Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call • PR Newswire (US) • 03/19/2024 01:00:00 PM
- Delcath Systems Appoints Martha S. Rook as Chief Operating Officer • PR Newswire (US) • 03/18/2024 09:20:00 PM
- Delcath Systems Announces $7 Million Private Placement • PR Newswire (US) • 03/15/2024 12:20:00 PM
- Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 03/08/2024 10:00:00 PM
- Delcath Systems to Participate in Upcoming Investor Conferences • PR Newswire (US) • 03/08/2024 02:00:00 PM
- Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System) • PR Newswire (US) • 02/22/2024 10:00:00 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM